Hemab Therapeutics Holdings, Inc. (COAG)
NMS · Healthcare · Biotechnology
$34.81
-1.49%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.63B
Shares Outstanding
46.7M
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (16.6M) | (16.1M) | (23.6M) | (26.1M) |
| Net Income | (15.3M) | (12.2M) | (22.7M) | (24.1M) |
| Diluted EPS | $-0.56 | $-0.44 | $-0.51 | $-0.80 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (50.4M) | (70.1M) |
| Net Income | (48.7M) | (63.9M) |
| Diluted EPS | $-1.77 | $-2.33 |